Rx oral solid opioids market share for morphine equivalents Canada 2017, by drug

Published by
Matej Mikulic,
Jan 26, 2021
In 2017, the prescription oral solid opioid morphine had a 14 percent share of the total market based on morphine equivalents sold in Canada. The opioid with the highest market share was oxycodone with 34 percent.

Percentage of the prescription oral solid opioid market in Canada based on morphine equivalents (MEQ) in 2017, by drug

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

January 2019

Region

Canada

Survey time period

2017

Supplementary notes

Morphine equivalents are a standardized measure used in this study to compare the relative potency of a milligram of each opioid to morphine.
Statistic includes prescription retail and hospital markets.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in CanadaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu